This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jan;2(1):143-4.

doi: 10.1001/jamaoncol.2015.4108.

Evaluating Chemotherapy at the End of Life

Hilde M Buiting¹, Michel M van den Heuvel¹

Affiliations

PMID: 26767556
DOI: 10.1001/jamaoncol.2015.4108

Comment

Evaluating Chemotherapy at the End of Life

Hilde M Buiting et al. JAMA Oncol. 2016 Jan.

. 2016 Jan;2(1):143-4.

doi: 10.1001/jamaoncol.2015.4108.

Authors

Hilde M Buiting¹, Michel M van den Heuvel¹

Affiliation

¹ Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, the Netherlands.

PMID: 26767556
DOI: 10.1001/jamaoncol.2015.4108

No abstract available

PubMed Disclaimer

Comment in

Evaluating Chemotherapy at the End of Life--Reply.
Prigerson HG, Neugut AI, Maciejewski PK. Prigerson HG, et al. JAMA Oncol. 2016 Jan;2(1):144. doi: 10.1001/jamaoncol.2015.4111. JAMA Oncol. 2016. PMID: 26767559 No abstract available.

Comment on

Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK. Prigerson HG, et al. JAMA Oncol. 2015 Sep;1(6):778-84. doi: 10.1001/jamaoncol.2015.2378. JAMA Oncol. 2015. PMID: 26203912 Free PMC article.

Similar articles

Evaluating Chemotherapy at the End of Life.
Provenzano AF, Carvajal RD. Provenzano AF, et al. JAMA Oncol. 2016 Jan;2(1):142-3. doi: 10.1001/jamaoncol.2015.4105. JAMA Oncol. 2016. PMID: 26767555 No abstract available.
Evaluating Chemotherapy at the End of Life.
Frickhofen N, Maier BO. Frickhofen N, et al. JAMA Oncol. 2016 Jan;2(1):142. doi: 10.1001/jamaoncol.2015.4102. JAMA Oncol. 2016. PMID: 26767554 No abstract available.
Evaluating Chemotherapy at the End of Life--Reply.
Prigerson HG, Neugut AI, Maciejewski PK. Prigerson HG, et al. JAMA Oncol. 2016 Jan;2(1):144. doi: 10.1001/jamaoncol.2015.4111. JAMA Oncol. 2016. PMID: 26767559 No abstract available.
Chemotherapy at end-of-life: an integration of oncology and palliative team.
Chan WL, Lam KO, Siu WK, Yuen KK. Chan WL, et al. Support Care Cancer. 2016 Mar;24(3):1421-7. doi: 10.1007/s00520-015-3031-z. Epub 2015 Nov 25. Support Care Cancer. 2016. PMID: 26604192 Review.
Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review.
Akhlaghi E, Lehto RH, Torabikhah M, Sharif Nia H, Taheri A, Zaboli E, Yaghoobzadeh A. Akhlaghi E, et al. Health Qual Life Outcomes. 2020 Oct 7;18(1):332. doi: 10.1186/s12955-020-01580-0. Health Qual Life Outcomes. 2020. PMID: 33028381 Free PMC article.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information